A nanoprobe and its preparation method and application
Through the fluorescence and colorimetric visual detection method combined with probe DNA and two-dimensional materials, the complex and expensive problems of existing gene detection technology are solved, and the rapid, low-cost and high-accuracy disease-related gene detection is achieved, which is suitable for economic underdogs Developed areas and areas with high incidence of epidemic diseases.
Patent Information
- Application Number
- CN202110674448.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-06-17
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2041-06-17
AI Technical Summary
The existing genetic testing technology is complex, expensive and not suitable for widespread applications in economically underdeveloped areas, especially in the early stages of accurate diagnosis and prognosis of diseases, which have problems such as cumbersome and high cost.
Using fluorescence and colorimetric visual detection methods based on probe DNA and two-dimensional materials, the combination of two-dimensional materials such as MoS2 nanosheets and metal cluster probes can achieve efficient fluorescence and colorimetric visual detection of disease-related genes, and simplify the detection process. and reduce costs.
It realizes fast, low-cost, high-accuracy and high-sensitivity disease-related genetic testing, avoids expensive equipment and complex experimental steps, and is suitable for economically underdeveloped areas and areas with high incidence of epidemic diseases.
Smart Images

Figure CN113493820B_ABST
Abstract
Description
Technical Field
[0001] The present application belongs to the technical field of medical detection, and in particular, relates to a nanoprobe and a preparation method and application thereof. Background Art
[0002] Abnormal DNA expression is closely related to the occurrence and development of many diseases, including cancer, hypertension, heart disease, diabetes, viral infection-related diseases such as hepatitis and new coronavirus pneumonia, etc., suggesting that disease-related genes can be regarded as diagnostic markers with important clinical significance, which are of great significance for the early and accurate diagnosis and prognosis of diseases. So far, traditional technologies used for genetic testing include polymerase chain reaction (PCR), gene sequencing, etc. Although they have high sensitivity, they rely on sophisticated instruments, cumbersome experimental procedures and experienced inspectors, which limits their widespread application, especially in economically underdeveloped developing countries. Therefore, it is still a challenge to explore simple and efficient analytical strategies for high-sensitivity and high-selectivity detection of DNA. Summary of the invention
[0003] In view of this, the present application provides a nanoprobe and a preparation method and application thereof, which effectively solve the technical defects of the existing detection process of disease-related genes, such as cumbersome detection, high cost, and time-consuming and labor-intensive.
[0004] In view of the shortcomings of the existing technology, including the need for complex and expensive instruments and cumbersome experimental steps, the present application provides a method based on probe DNA and two-dimensional materials to achieve efficient fluorescence and colorimetric visualization detection of disease-related target genes. It is a fast, low-cost, highly accurate, highly sensitive and simple detection method.
[0005] The first aspect of the present application provides a fluorescent and colorimetric visualization nanoprobe, comprising:
[0006] Two-dimensional materials and probe DNA;
[0007] The two-dimensional material is a two-dimensional material that can adsorb the probe DNA, or the two-dimensional material can be used as a substrate to synthesize a two-dimensional material-metal nanoparticle complex for catalytic colorimetric detection;
[0008] The probe DNA can be complementary to the target gene associated with the disease;
[0009] The binding force between the complementary pairing of the probe DNA and the target gene is greater than the binding force between the probe DNA and the two-dimensional material.
[0010] In another embodiment, when the two-dimensional material is a two-dimensional material that adsorbs the probe DNA, the two-dimensional material is selected from one or more of molybdenum disulfide nanosheets, tungsten disulfide nanosheets, two-dimensional covalent organic frameworks, graphene, hexagonal boron nitride, black phosphorus, two-dimensional zinc oxide and Mxene.
[0011] Preferably, the two-dimensional material is molybdenum disulfide (MoS2) nanosheets.
[0012] Specifically, the diameter of the MoS2 nanosheets is 100-200nm.
[0013] Specifically, MoS2 is a two-dimensional layered transition metal chalcogenide nanosheet with high specific surface area, easy surface modification, low cytotoxicity and excellent photothermal performance, which can be used to detect target genes of diseases.
[0014] In another embodiment, the probe DNA is used to prepare a metal cluster probe;
[0015] The fluorescent metal cluster of the metal cluster probe is selected from one or more of silver nanoclusters, gold nanoclusters, platinum nanoclusters, copper nanoclusters, gold-silver nanoclusters and platinum-silver nanoclusters.
[0016] Specifically, the fluorescent metal cluster is prepared by a mixed reaction of probe DNA, a soluble metal salt solution and a reducing agent; the metal cluster probe is a silver nanocluster probe, a gold nanocluster probe, a platinum nanocluster probe, a copper nanocluster probe, a gold-silver nanocluster probe and a platinum-silver nanocluster probe.
[0017] Specifically, the two-dimensional material adsorbs the metal cluster probe to quench the fluorescence of the fluorescent metal cluster.
[0018] Specifically, the method for preparing the silver nanocluster probe includes: mixing probe DNA, AgNO3, and NaBH4 in a phosphate buffer or a sodium cocoate buffer to obtain the silver nanocluster probe.
[0019] Among them, the probe DNA and Ag + The molar ratio of Ag is 1:6, or 1:8; + The molar ratio with NaBH4 is 1:1, or 2:1.
[0020] Specifically, the silver nanocluster probe has excellent fluorescence properties and can produce a fluorescence emission band in the visible to near-infrared range.
[0021] Specifically, the present application synthesizes metal cluster probes with different emission wavelengths and fluorescence properties by regulating the sequence of the probe DNA and the reaction conditions, which can be used to detect target genes related to diseases.
[0022] In another embodiment, the nanoprobe further comprises fluorescence-enhanced DNA; the fluorescence-enhanced DNA forms a complementary pair with a portion of the target gene DNA; the fluorescence-enhanced DNA, the probe DNA and the target gene complementarily pair to form a hybrid structure.
[0023] Specifically, the mixing molar ratio of the silver nanocluster probe to the fluorescence enhanced DNA is 1:1.
[0024] Specifically, the sequence of the probe DNA is divided into two parts, one part is complementary to the target gene part of the disease to be detected, and the other part is the template for synthesizing the metal cluster probe. By designing two different template sequences, two metal cluster probes with different excitation and emission are obtained, which are used to respectively detect the target genes of two different diseases.
[0025] In another embodiment, the number of the probe DNAs is 2, 3, 4, 5 or 6; when the number of the probe DNAs is greater than 1, no complementary pairing occurs between all the probe DNAs.
[0026] In another embodiment, the probe DNA has one or more of the nucleotide sequences shown in SEQ ID No: 1, SEQ ID No: 2 and SEQ ID No: 3; the fluorescence enhanced DNA has the nucleotide sequence shown in SEQ ID No: 4 or / and the nucleotide sequence shown in SEQ ID No: 5.
[0027] Specifically, the number of the probe DNAs is 3, and the probe DNA has a nucleic acid sequence as shown in SEQ ID No: 1, and the sequence of SEQ ID No: 1 is: 5'-CCCATATACCCCGGTGCAGTTTCCGTCCGTAG-3'; the probe DNA has a nucleic acid sequence as shown in SEQ ID No: 2, and the sequence of SEQ ID No: 2 is: 5'-CCCCACCCCTCCCCCAACTCCTCCCA-3'; the probe DNA has a nucleic acid sequence as shown in SEQ ID No: 3, and the sequence of SEQ ID No: 3 is: 5'-ACCTTTAACCTAATCTCCTCCCCCAACTCCTCCCA-3'.
[0028] Specifically, MoS2 nanosheets can effectively quench the fluorescence of silver nanocluster probes. Compared with silver nanocluster probes, MoS2 nanosheets are large in size, so there is enough space to adsorb and quench the fluorescence of silver nanocluster probes, and there is no competition between MoS2 nanosheets and silver nanocluster probes.
[0029] Specifically, the number of the fluorescence-enhanced DNAs is 2, and the fluorescence-enhanced DNA has a nucleic acid sequence as shown in SEQ ID No: 4, and the sequence of SEQ ID No: 4 is: 5'-ATGATGGGTATGGGAATACAGGGTGGGGTGGGGTGGGG-3'; the fluorescence-enhanced DNA has a nucleic acid sequence as shown in SEQ ID No: 5, and the sequence of SEQ ID No: 5 is: 5'-ACCTTTAACCTAATCTCCTCCCGTTTT-3'.
[0030] Among them, the fluorescence-enhanced DNA forms a complementary pair with a portion of the target gene DNA; when the disease-related target gene is mixed and incubated with the metal cluster probe containing the probe DNA and the fluorescence-enhanced DNA, the disease-related target gene is used to hybridize the fluorescence-enhanced DNA with the probe DNA to shorten the distance, thereby achieving fluorescence enhancement of the metal cluster probe.
[0031] Specifically, before the nanoprobe is used, the two-dimensional material is separated from the probe DNA.
[0032] The present application constructs two different probe DNAs and two different fluorescence-enhanced DNAs (a DNA green-luminescence-enhanced sequence rich in cytosine and thymine (CT) and a DNA red-luminescence-enhanced sequence rich in guanine (G)), which can simultaneously detect two segments of target genes and effectively reduce false positives.
[0033] In another embodiment, when the two-dimensional material is used as a substrate to synthesize a two-dimensional material-metal nanoparticle complex for catalytic colorimetric detection, the metal nanoparticles are selected from one or more of platinum nanoparticles, palladium nanoparticles, gold nanoparticles, silver nanoparticles, copper nanoparticles, palladium-platinum nanoparticles, platinum-gold nanoparticles, platinum-silver nanoparticles, platinum-copper nanoparticles, silver-copper nanoparticles, gold-palladium-platinum nanoparticles and gold-silver-platinum nanoparticles.
[0034] The second aspect of the present application provides a method for preparing the nanoprobe, wherein the method for preparing the metal cluster probe comprises: mixing probe DNA, a soluble metal salt solution and a reducing agent to obtain the metal cluster probe. The metal cluster probe is a fluorescent probe.
[0035] Specifically, the soluble metal salt solution is a soluble silver salt solution, a soluble gold salt solution, a soluble platinum salt solution, a soluble copper salt solution, a soluble gold salt plus silver salt mixed solution, and a soluble platinum salt plus silver salt mixed solution; the reducing agent is an existing conventional reducing agent.
[0036] Specifically, the soluble metal salt solution is AgNO3; and the reducing agent is NaBH4.
[0037] The third aspect of the present application provides a method for preparing the nanoprobe, and the method for preparing the two-dimensional material-metal nanoparticle composite comprises:
[0038] The two-dimensional material, a soluble metal salt solution and a reducing agent are mixed and reacted to prepare a two-dimensional material-metal nanoparticle composite.
[0039] Specifically, the soluble metal in the soluble metal salt solution is a conventional color developing metal ion, such as Pt 4 + , Pd 4+ 、Au 3+ 、Ag + and Cu 2+ One or more of the following, corresponding to one or more of the metal salts H2PtCl6, K2PdCl6, HAuCl4, AgNO3 and CuCl2; the reducing agent is an existing conventional reducing agent, such as ascorbic acid and / or NaBH4.
[0040] Specifically, the two-dimensional material-metal nanoparticle complex is used as a colorimetric probe to perform a color development reaction in a system consisting of H2O2, a color developer and a buffer solution; the color developer is an existing conventional color developer, such as 3,3',5,5'-tetramethylbenzidine (TMB); and the buffer solution is an existing conventional buffer, such as phosphate buffer saline (PBS).
[0041] The fourth aspect of the present application discloses the use of the nanoprobe or the nanoprobe prepared by the preparation method in the preparation of a target gene product for detecting disease-related diseases.
[0042] The fifth aspect of the present application provides a kit for detecting a disease-related target gene, comprising: the nanoprobe.
[0043] When using the above kit, the two-dimensional material and the probe DNA can be mixed to form a complex, and then added to the sample to be tested to detect the target gene; or the sample to be tested and the probe DNA can be mixed first, and then the two-dimensional material can be added for a mixed reaction; or the sample to be tested, the probe DNA and the fluorescence-enhanced DNA can be mixed first, and then the two-dimensional material can be added for a mixed reaction.
[0044] The nanoprobe includes MoS2 nanosheets, fluorescence-enhanced DNA and metal cluster probes; when used, metal cluster probes and fluorescence-enhanced DNA are first added to the sample to be tested. If the sample to be tested contains a disease-related target gene, due to the influence of DNA hybridization kinetics, the target gene will first form a complementary T-shaped double-stranded structure after being directly mixed with the metal cluster probe containing probe DNA and the fluorescence-enhanced DNA; then after adding the MoS2 nanosheet, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed to the surface of the MoS2 nanosheet, and the fluorescence of the metal cluster probe can be restored, and finally the fluorescence content is detected in the system. Among them, the target gene can effectively shorten the distance between the fluorescence-enhanced DNA and the metal cluster probe through sequence complementarity, so that the fluorescence of the metal cluster probe is further significantly improved.
[0045] When used, metal cluster probes and fluorescence-enhanced DNA are first added to the sample to be tested. If the sample to be tested does not contain the disease-related target gene, the metal cluster probe and the fluorescence-enhanced DNA do not hybridize. Then, after adding the MoS2 nanosheet, the unhybridized metal cluster probe and the fluorescence-enhanced DNA containing the probe DNA can be adsorbed on the MoS2 surface through the van der Waals force between the MoS2 nanosheet and the DNA molecule base, so that the fluorescence of the metal cluster probe is quenched, and the fluorescence cannot be detected without the target gene. At the same time, the fluorescence-enhanced DNA (DNA green luminescence enhancement sequence rich in cytosine thymine (CT) and red fluorescence enhancement sequence rich in guanine (G)) is also adsorbed to the MoS2 nanosheet.
[0046] The fifth aspect of the present application provides a kit for detecting a target gene of a disease, comprising: the nanoprobe, a reducing agent, metal ions, H2O2, a color developer and a buffer.
[0047] Specifically, the soluble metal ions in the soluble metal salt solution are metal ions conventionally used to synthesize nano-metal particles with catalytic activity, such as Pt 4+ , Pd 4+ 、Au 3+ 、Ag + and Cu 2+ One or more of .
[0048] Specifically, the reducing agent is a conventional reducing agent, such as ascorbic acid and / or NaBH4; the color developer is a conventional color developer, such as 3,3',5,5'-tetramethylbenzidine (TMB); and the buffer is a conventional buffer, such as phosphate buffered saline (PBS).
[0049] The nanoprobe includes a MoS2 nanosheet and a probe DNA. When used, the probe DNA is added to the sample to be tested. If the sample to be tested contains a target gene related to a disease, the target gene is directly complementary to the probe DNA due to the influence of DNA hybridization dynamics; then the MoS2 nanosheet is added, the probe DNA does not bind to the MoS2 nanosheet, the MoS2 nanosheet is obtained by centrifugation, and then the MoS2 nanosheet is dispersed in a solution to obtain a MoS2 nanosheet aqueous solution; then the MoS2 nanosheet aqueous solution, ascorbic acid, and H2PtCl6 are mixed and reacted to obtain a two-dimensional material-metal nanoparticle complex (MoS2-PtNPs complex nanozyme); the MoS2-PtNPs complex nanozyme, H2O2, and TMB are incubated in a buffer solution, and finally detected by colorimetry. The MoS2-PtNPs complex plays a role in peroxidase catalytic activity, catalyzing TMB oxidation color development, and changing from colorless to blue.
[0050] When used, probe DNA is added to the sample to be tested. If the sample to be tested does not contain the target gene related to the disease, then MoS2 nanosheets are added, and the probe DNA will be adsorbed on the surface of the MoS2 nanosheet to form a probe DNA-MoS2 nanosheet complex. The probe DNA-MoS2 nanosheet complex is obtained by centrifugation, and then dispersed in a solution to obtain a probe DNA-MoS2 nanosheet aqueous solution; then the probe DNA-MoS2 nanosheet aqueous solution, ascorbic acid, and H2PtCl6 are mixed for reaction. Since the site for synthesizing metal nanoparticles is occupied by DNA, platinum nanoparticles (PtNPs) cannot grow on MoS2, and a probe DNA-MoS2 nanosheet is obtained; the probe DNA-MoS2 nanosheet, H2O2, and TMB are incubated in a buffer solution, and finally detected by colorimetry. The probe DNA-MoS2 nanosheet does not have peroxidase catalytic activity, cannot catalyze TMB oxidation and color development, and the color of the solution does not change.
[0051] Specifically, the kit of the present application is to grow PtNPs on MoS2 to regulate the peroxidase activity of MoS2-PtNPs. By synthesizing PtNPs in situ on the surface of MoS2, MoS2 can be used as a substrate for preparing a two-dimensional material-metal nanoparticle complex (MoS2-PtNPs complex nanozyme), thereby significantly improving the enzyme activity of the complex nanozyme. The probe DNA can be effectively adsorbed to the MoS2 surface due to the strong interaction between the probe DNA and the MoS2 nanosheet, thereby effectively preventing the growth of PtNPs on the MoS2 surface, thereby greatly reducing the catalytic activity of the complex nanozyme. In the presence of the target gene, the target gene and the probe DNA will form double-stranded DNA, and the formation of a double-stranded structure will hinder the adsorption of the probe DNA on the MoS2 nanosheet, thereby restoring the growth of PtNPs, forming a MoS2-PtNPs complex nanozyme, and the enzyme activity is significantly improved. Therefore, the visual colorimetric detection of the target gene can be effectively realized by using the characteristic of the target gene to regulate the catalytic activity of the complex nanozyme.
[0052] In another embodiment, the disease-related target gene is a sequence of bacteria or viruses that cause the disease, and the target gene for detecting the disease is HBV DNA, or other viral DNA, such as COVID-19.
[0053] It can be seen that the nanoprobe provided in the present application, as well as its preparation method and application, can simply detect the target gene by fluorescence or colorimetry; can realize the fluorescence or colorimetric visualization detection of the target gene, and can realize the detection of the target gene directly by naked eye observation. The nanoprobe of the present application has good accuracy and stability, and can realize the detection of target genes in human serum samples. In summary, the nanoprobe of the present application has the potential for disease-related target gene detection, and is particularly suitable for developing countries with limited medical and instrument support and areas with high incidence of epidemic diseases. The nanoprobe of the present application has a simple structure, fast operation, no need for expensive equipment, and avoids complex experimental techniques. BRIEF DESCRIPTION OF THE DRAWINGS
[0054] In order to more clearly illustrate the technical solutions in the embodiments of the present application or the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below.
[0055] Figure 1The process of detecting target genes by using fluorescent and colorimetric visualization nanoprobes provided in the embodiments of the present application; a and b are schematic diagrams of detecting HBV DNA using MoS2-AgNCs nanocomplexes; c and d are schematic diagrams of colorimetric detection of HBV DNA by regulating the peroxidase activity of MoS2-PtNPs nanocomplexes through HBV DNA. Wherein, Probe DNA is probe DNA, Enhancer DNA is fluorescence enhanced DNA, Target DNA is disease-related target gene, and No Target is the absence of disease-related target gene;
[0056] Figure 2 Characterization of the interaction between DNA-AgNCs A and MoS2 nanosheets provided in the embodiments of the present application; a is a TEM image of DNA-AgNCs A, scale bar, 20 nm; b is a TEM image of MoS2 nanosheets, scale bar, 100 nm; c is a normalized absorption spectrum of MoS2 nanosheets and DNA-AgNCs-MoS2 mixture; d is a TEM image of DNA-AgNCs-MoS2 mixture, scale bar, 10 nm;
[0057] Figure 3 The fluorescence detection results of the nanoprobes of different components provided in the examples of the present application for detecting the HBV DNA target gene;
[0058] Figure 4 The fluorescence detection results of the DNA-AgNCs and fluorescence-enhanced DNA provided in the examples of the present application for detecting HBV DNA target genes of different concentrations;
[0059] Figure 5 The relative fluorescence intensity test results of different target genes detected by different nanoprobes provided in the examples of this application; M / F H , where F H is the fluorescence intensity when the target gene is present, and F M is the fluorescence intensity in the presence of single-base mismatch (SM), triple-base mismatch (TM), and completely mismatched (CM) DNA chains;
[0060] Figure 6 The fluorescence spectra of the nanoprobe provided in the embodiments of the present application for detecting different amounts of HBV DNA target genes;
[0061] Figure 7 The characterization and catalytic activity of MoS2-PtNPs containing the HBV DNA target gene T1 are provided for the examples of this application;
[0062] Figure 8The absorption spectrum and selectivity results of MoS2-PtNPs containing the HBV DNA target gene T1 are provided for the examples of the present application. DETAILED DESCRIPTION
[0063] The present application provides a fluorescent and colorimetric visualized nanoprobe and a preparation method and application thereof, which are used to solve the technical defects of the prior art in disease detection, such as complicated steps, high cost, time-consuming and labor-intensive.
[0064] The technical solutions in the embodiments of the present application are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present application.
[0065] Wherein, the raw materials used in the following examples are all commercially available or homemade.
[0066] In the following embodiments:
[0067] Probe DNA P1 is SEQ ID No: 1;
[0068] Its sequence is: 5'-CCCATATACCCCGGTGCAGTTTCCGTCCGTAG-3'.
[0069] Probe DNA P2 is SEQ ID No: 2;
[0070] Its sequence is: 5'-CCCCACCCCTCCCCCAACTCCTCCCA-3'.
[0071] The colorimetric detection DNA probe P3 is SEQ ID No: 3;
[0072] Its sequence is: 5'-ACCTTTAACCTAATCTCCTCCCCCAACTCCTCCCA-3'.
[0073] Fluorescence enhanced DNA E1 is SEQ ID No: 4;
[0074] The sequence is:
[0075] 5'-ATGATGGGTATGGGAATACAGGGTGGGGTGGGGTGGGG-3'.
[0076] Fluorescence enhanced DNA E2 is SEQ ID No: 5;
[0077] Its sequence is: 5'-ACCTTTAACCTAATCTCCTCCCGTTTT-3'.
[0078] HBV DNA target gene T1 is SEQ ID No: 6;
[0079] The sequence is:
[0080] 5'-CTACGGACGGAAACTGCACCTGTATTCCCATACCCATCAT-3'.
[0081] The HBV DNA target gene T2 is SEQ ID No: 7;
[0082] Its sequence is: 5'-TGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGT-3'.
[0083] The HBV DNA single base mismatch target gene (SM1) is SEQ ID No: 8;
[0084] The sequence is:
[0085] 5'-CTACGGACGGAAACTGCAACTGTATTCCCATACCCATCAT-3'
[0086] The HBV DNA three-base mismatch target gene (TM1) is SEQ ID No: 9;
[0087] The sequence is:
[0088] 5'-CTATGGACGGAAACTGCAACTGTATTCCCATACCCATAAT-3'
[0089] The HBV DNA completely mismatched target gene (CM1) is SEQ ID No: 10;
[0090] The sequence is:
[0091] 5'-CCTTAAGTAACTACTGTAGAGGTCTACGGATTATGCGATC-3'
[0092] The HBV DNA single base mismatch target gene (SM2) is SEQ ID No: 11;
[0093] Its sequence is: 5'-TGGGAGGAGTTGGCGGAGGAGATTAGGTTAAAGGT-3'
[0094] The HBV DNA three-base mismatch target gene (TM2) is SEQ ID No: 12;
[0095] Its sequence is: 5'-TGAGAGGAGTTGGCGGAGGAGATTAGGTTAACGGT-3'
[0096] The HBV DNA completely mismatched target gene (CM2) is SEQ ID No: 13;
[0097] Its sequence is: 5'-CCTTAAGTAACTACTGTAGAGGTCTACGGATTATG-3'
[0098] The MoS2 nanosheets used in the following examples were purchased from Nanjing Xianfeng Nanomaterial Technology Co., Ltd. (XF135). The TEM images of the MoS2 nanosheets were measured. Figure 2 As shown in b, Figure 2 b is a TEM image of MoS2 nanosheets provided in this application.
[0099] The tungsten disulfide nanosheets, two-dimensional covalent organic framework nanosheets, graphene nanosheets, boron nitride nanosheets, black phosphorus nanosheets, zinc oxide nanosheets, and Mxene nanosheets used in the following examples were purchased from Nanjing Xianfeng Nanomaterial Technology Co., Ltd.
[0100] The HBV DNA target gene T1, HBV DNA target gene T2, HBV DNA single-base mismatch target gene (SM1), HBV DNA three-base mismatch target gene (TM1), HBV DNA three-base mismatch target gene (CM1), HBV DNA single-base mismatch target gene (SM2), HBV DNA three-base mismatch target gene (TM2) and HBV DNA three-base mismatch target gene (CM2) in the following examples were added to diluted human standard serum samples (10%) and used to simulate actual samples.
[0101] Example 1
[0102] The present application example provides two silver nanocluster probes (DNA-AgNCs A and DNA-AgNCs B), and the specific preparation method includes:
[0103] The probe DNA P1 (1 μM), AgNO3 (6 μM) and NaBH4 (6 μM) were mixed in a buffer solution (10 mM phosphate buffer, pH 7.0), vortexed vigorously for 2 minutes, and then incubated in the dark at room temperature for 5 hours to obtain DNA-AgNCs A, which was then stored in a refrigerator at 4 °C for future use. + The molar ratio of Ag is 1:6. + The molar ratio with NaBH4 is 1:1.
[0104] 1 μM probe DNA P2, 8 μM AgNO3, 4 μM NaBH4 and sodium cocoate buffer (5 mM, pH 6.95) were mixed, shaken vigorously for 2 min, and then treated with 400 psi oxygen at room temperature for 2 h to prepare DNA-AgNCs B, which were then stored in a 4°C refrigerator for use.
[0105] The TEM image of DNA-AgNCs A provided in the examples of this application is measured, such as Figure 2 As shown in a, Figure 2 a is a TEM image of DNA-AgNCs A prepared in the example of the present application.
[0106] The DNA-AgNCs A was mixed with MoS2 nanosheets to obtain a DNA-AgNCs-MoS2 mixture, and the absorption spectra of the DNA-AgNCs-MoS2 mixture and the MoS2 nanosheets were measured, as well as the TEM image of the DNA-AgNCs-MoS2 mixture. Figure 2 c and Figure 2 As shown in d, Figure 2 c is the absorption spectra of MoS2 nanosheets and DNA-AgNCs-MoS2 mixture provided in this application, Figure 2 d is the TEM image of the DNA-AgNCs-MoS2 mixture provided in this application.
[0107] Example 2
[0108] The present application provides a gold nanocluster probe (DNA-AuNCs), and the preparation method thereof is as follows:
[0109] The probe DNA P1 (1 μM), HAuCl4 (6 μM) and ascorbic acid (AA, 6 μM) were mixed in a buffer solution (10 mM phosphate buffer, pH 7.0), vortexed vigorously for 2 minutes, and then incubated in the dark at room temperature for 5 hours to prepare DNA-AuNCs, which were then stored in a refrigerator at 4 °C for future use. - The molar ratio of AuCl4 is 1:6. - The molar ratio with AA is 1:1.
[0110] The present application performs transmission electron microscopy test on the obtained DNA-AuNCs, and the test results show that the particle size of the DNA-AuNCs obtained in Example 2 of the present application is 1 to 4 nanometers.
[0111] Example 3
[0112] The present application example provides a platinum nanocluster probe (DNA-PtNCs), and the preparation method thereof is as follows:
[0113] The probe DNA P1 (1 μM), H2PtCl6 (6 μM) and ascorbic acid (AA, 6 μM) were mixed in a buffer solution (10 mM phosphate buffer, pH 7.0), vortexed vigorously for 2 minutes, and then incubated in the dark at room temperature for 5 hours to prepare DNA-PtNCs, which were then stored in a refrigerator at 4 °C for future use. 2- The molar ratio of PtCl6 is 1:6 2- The molar ratio with AA is 1:1.
[0114] The present application performs transmission electron microscopy test on the obtained DNA-PtNCs, and the test results show that the particle size of the DNA-PtNCs obtained in Example 3 of the present application is 1 to 3.5 nanometers.
[0115] Example 4
[0116] The present application example provides a copper nanocluster probe (DNA-CuNCs), and the preparation method thereof is as follows:
[0117] The probe DNA P1 (1 μM), CuCl2 (6 μM) and ascorbic acid (AA, 6 μM) were mixed in a buffer solution (10 mM phosphate buffer, pH 7.0), vortexed vigorously for 2 minutes, and then incubated in the dark at room temperature for 5 hours to prepare DNA-CuNCs, which were then stored in a refrigerator at 4°C for future use. 2+ The molar ratio of Cu is 1:6. 2+ The molar ratio with AA is 1:1.
[0118] The present application performs transmission electron microscopy test on the obtained DNA-CuNCs, and the test results show that the particle size of the DNA-CuNCs obtained in Example 4 of the present application is 2 to 5 nanometers.
[0119] Example 5
[0120] The present application example provides a gold-silver nanocluster probe (DNA-Au / AgNCs), and the preparation method thereof is as follows:
[0121] The probe DNA P1 (1 μM), HAuCl4 (3 μM), AgNO3 (3 μM) and NaBH4 (6 μM) were mixed in a buffer solution (10 mM phosphate buffer, pH 7.0), vortexed vigorously for 2 minutes, and then incubated in the dark at room temperature for 5 hours to prepare DNA-Au / AgNCs, which were then stored in a refrigerator at 4 °C for future use. - and Ag + The molar ratio of AuCl4 is 1:3:3. -:Ag + : The molar ratio of ascorbic acid is 1:1:2.
[0122] The present application performs transmission electron microscopy test on the obtained DNA-Au / AgNCs, and the test results show that the particle size of the DNA-Au / AgNCs obtained in Example 5 of the present application is 1 to 4 nanometers.
[0123] Example 6
[0124] The present application example provides a platinum-silver nanocluster probe (DNA-Pt / AgNCs), and the preparation method thereof is as follows:
[0125] The probe DNA P1 (1 μM), H2PtCl6 (3 μM), AgNO3 (3 μM) and NaBH4 (6 μM) were mixed in a buffer solution (10 mM phosphate buffer, pH 7.0), vortexed vigorously for 2 minutes, and then incubated in the dark at room temperature for 5 hours to prepare DNA-Pt / AgNCs, which were then stored in a refrigerator at 4 °C for future use; 2- and Ag + The molar ratio of PtCl6 is 1:3:3. 2- :Ag + : The molar ratio of ascorbic acid is 1:1:2.
[0126] The present application performs transmission electron microscopy test on the obtained DNA-Pt / AgNCs, and the test results show that the particle size of the DNA-Pt / AgNCs obtained in Example 6 of the present application is 1 to 3.5 nanometers.
[0127] Example 7
[0128] The present application example provides a fluorescence detection test for HBV DNA target gene, and the specific steps include: a fluorescence test for detecting HBV DNA target gene using nanoprobes of different components:
[0129] The DNA-AgNCs A of Example 1 and the fluorescence enhanced DNA E1 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 3 a is shown as curve 1.
[0130] The DNA-AgNCs A of Example 1 and the fluorescence-enhanced DNA E1 (200 nM) were mixed in a molar ratio of 1:1 to obtain a mixture. Thereafter, the mixture was mixed with 50 μg / mL MoS2 nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 3 a is shown as curve 2.
[0131] DNA-AgNCs A (200 nM) of Example 1 and fluorescence-enhanced DNA E1 were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with HBV DNA target gene T1 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 3 a is shown as curve 3.
[0132] The DNA-AgNCs B of Example 1 and the fluorescence-enhanced DNA E2 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 3 b is shown as curve 1.
[0133] The DNA-AgNCs B of Example 1 and the fluorescence-enhanced DNA E2 (200 nM) were mixed in a molar ratio of 1:1 to obtain a mixture. Thereafter, the mixture was mixed with 50 μg / mL MoS2 nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 3 b is shown in curve 2.
[0134] DNA-AgNCs B of Example 1 and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with HBV DNA target gene T2 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 3 b is shown as curve 3.
[0135] Figure 3 The fluorescence detection test of the nanoprobes of different components provided in the embodiment of the present application for detecting the target gene of HBV DNA is as follows: Figure 3 a and Figure 3 Curve 3 of Figure b shows that when the HBV DNA target gene is directly mixed with DNA-AgNCs and fluorescence-enhanced DNA, a complementary T-shaped double-stranded structure will first be formed; then, after the MoS2 nanosheets are added, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed on the surface of the MoS2 nanosheets, and the fluorescence of the DNA-AgNCs will be restored, and the fluorescence can be detected in the system. Figure 3 a and Figure 3From curves 1 and 2 of b, it can be seen that the system does not contain MoS2 nanosheets or HBV DNA target gene, and DNA-AgNCs and fluorescence-enhanced DNA do not hybridize with the HBV DNA target gene. After the MoS2 nanosheets are added, the unhybridized single-stranded DNA-AgNCs and fluorescence-enhanced DNA can be adsorbed on the MoS2 surface through the van der Waals force between the MoS2 nanosheets and the bases in the DNA, which quenches the fluorescence of the DNA-AgNCs and makes it impossible to detect fluorescence in the system.
[0136] Example 8
[0137] The present application example provides a fluorescence detection test for HBV DNA target gene, and the specific steps include: a fluorescence test for detecting HBV DNA target gene using nanoprobes of different components:
[0138] The DNA-AgNCs A of Example 1 and the fluorescence-enhanced DNA E1 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0139] The DNA-AgNCs A of Example 1 and the fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. The mixture was then mixed with 50 μg / mL tungsten disulfide nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0140] The DNA-AgNCs A (200 nM) of Example 1 and the fluorescence-enhanced DNA E1 were mixed at a molar ratio of 1:1 to obtain a mixture. Thereafter, the mixture was hybridized with the HBV DNA target gene T1 (200 nM) for 30 minutes, and 50 μg / mL tungsten disulfide nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0141] When the HBV DNA target gene is directly mixed with DNA-AgNCs and fluorescence-enhanced DNA, a complementary T-shaped double-stranded structure will be formed first; then, after the addition of tungsten disulfide nanosheets, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed to the surface of the tungsten disulfide nanosheets, and the fluorescence of DNA-AgNCs will be restored, and the fluorescence can be detected in the system. When the system does not contain tungsten disulfide nanosheets or HBV DNA target genes, DNA-AgNCs and fluorescence-enhanced DNA do not hybridize with the HBV DNA target gene, and then after the addition of tungsten disulfide nanosheets, the unhybridized single-stranded DNA-AgNCs and fluorescence-enhanced DNA can be adsorbed on the tungsten disulfide surface through the van der Waals force between the tungsten disulfide nanosheets and the bases in the DNA, so that the fluorescence of DNA-AgNCs is quenched, and the fluorescence cannot be detected in the system.
[0142] Example 9
[0143] The present application example provides a fluorescence test for detecting HBV DNA target gene using nanoprobes of different components, and the specific steps include:
[0144] The DNA-AgNCs B of Example 1 and the fluorescence-enhanced DNA E2 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0145] The DNA-AgNCsB of Example 1 and the fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. The mixture was then mixed with 50 μg / mL of the two-dimensional covalent organic framework nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0146] DNA-AgNCs B (200 nM) and fluorescence-enhanced DNA E2 of Example 1 were mixed in a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with the HBV DNA target gene T2 (200 nM) for 30 minutes, and 50 μg / mL of two-dimensional covalent organic framework nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. Among them, the two-dimensional covalent organic framework nanosheet is [Zn4O(BDC)3](DMF)8(C6H5Cl) (MOF-5, H2BDC=1,4-phthalic acid, DMF=N,N-dimethylformamide).
[0147] When the HBV DNA target gene is directly mixed with DNA-AgNCs and fluorescence-enhanced DNA, a complementary T-shaped double-stranded structure will be formed first; then, after the addition of the two-dimensional covalent organic framework nanosheet, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed to the surface of the two-dimensional covalent organic framework nanosheet, and the fluorescence of DNA-AgNCs will be restored, and the fluorescence can be detected in the system. When the system does not contain two-dimensional covalent organic framework nanosheets or HBV DNA target genes, DNA-AgNCs and fluorescence-enhanced DNA do not hybridize with the HBV DNA target gene, and then after the addition of the two-dimensional covalent organic framework nanosheet, the unhybridized single-stranded DNA-AgNCs and fluorescence-enhanced DNA can be adsorbed on the surface of the two-dimensional covalent organic framework nanosheet through the van der Waals force between the two-dimensional covalent organic framework nanosheet and the bases in the DNA, so that the fluorescence of DNA-AgNCs is quenched, and the fluorescence cannot be detected in the system.
[0148] Example 10
[0149] The present application example provides a fluorescence test for detecting HBV DNA target gene using nanoprobes of different components, and the specific steps include:
[0150] The DNA-AgNCs A of Example 1 and the fluorescence-enhanced DNA E1 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0151] The DNA-AgNCs A of Example 1 and the fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. The mixture was then mixed with 50 μg / mL graphene nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0152] The DNA-AgNCs A (200 nM) of Example 1 and the fluorescence-enhanced DNA E1 were mixed at a molar ratio of 1:1 to obtain a mixture. Thereafter, the mixture was hybridized with the HBV DNA target gene T1 (200 nM) for 30 minutes, and 50 μg / mL of graphene nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0153] When the HBV DNA target gene is directly mixed with DNA-AgNCs and fluorescence-enhanced DNA, a complementary T-shaped double-stranded structure will be formed first; then, after adding graphene nanosheets, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed to the surface of the graphene nanosheets, and the fluorescence of DNA-AgNCs will be restored, and fluorescence can be detected in the system. When the system does not contain graphene nanosheets or HBV DNA target genes, DNA-AgNCs and fluorescence-enhanced DNA do not hybridize with the HBV DNA target gene, and then after adding graphene nanosheets, the unhybridized single-stranded DNA-AgNCs and fluorescence-enhanced DNA can be adsorbed on the graphene surface through the van der Waals force between the graphene nanosheets and the bases in the DNA, which quenches the fluorescence of DNA-AgNCs and makes it impossible to detect fluorescence in the system.
[0154] Embodiment 11
[0155] The present application example provides a fluorescence test for detecting HBV DNA target gene using nanoprobes of different components, and the specific steps include:
[0156] The DNA-AgNCs B of Example 1 and the fluorescence-enhanced DNA E2 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0157] The DNA-AgNCs B of Example 1 and the fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. The mixture was then mixed with 50 μg / mL hexagonal boron nitride nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0158] The DNA-AgNCs B (200 nM) of Example 1 and the fluorescence-enhanced DNA E2 were mixed at a molar ratio of 1:1 to obtain a mixture. Thereafter, the mixture was hybridized with the HBV DNA target gene T2 (200 nM) for 30 minutes, and 50 μg / mL hexagonal boron nitride nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0159] When the HBV DNA target gene is directly mixed with DNA-AgNCs and fluorescence-enhanced DNA, a complementary T-shaped double-stranded structure will be formed first; then, after the addition of hexagonal boron nitride nanosheets, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed on the surface of the hexagonal boron nitride nanosheets, and the fluorescence of DNA-AgNCs will be restored, and fluorescence can be detected in the system. When the system does not contain hexagonal boron nitride nanosheets or HBV DNA target genes, DNA-AgNCs and fluorescence-enhanced DNA do not hybridize with the HBV DNA target gene, and then after the addition of hexagonal boron nitride nanosheets, the unhybridized single-stranded DNA-AgNCs and fluorescence-enhanced DNA can be adsorbed on the hexagonal boron nitride surface through the van der Waals force between the hexagonal boron nitride nanosheets and the bases in the DNA, which quenches the fluorescence of DNA-AgNCs and makes it impossible to detect fluorescence in the system.
[0160] Example 12
[0161] The present application example provides a fluorescence test for detecting HBV DNA target gene using nanoprobes of different components, and the specific steps include:
[0162] The DNA-AgNCs A of Example 1 and the fluorescence enhanced DNA E1 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0163] The DNA-AgNCs A of Example 1 and the fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. The mixture was then mixed with 50 μg / mL black phosphorus nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0164] The DNA-AgNCs A (200 nM) of Example 1 and the fluorescence-enhanced DNA E1 were mixed at a molar ratio of 1:1 to obtain a mixture. Thereafter, the mixture was hybridized with the HBV DNA target gene T1 (200 nM) for 30 minutes, and 50 μg / mL black phosphorus nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0165] When the HBV DNA target gene is directly mixed with DNA-AgNCs and fluorescence-enhanced DNA, a complementary T-shaped double-stranded structure will be formed first; then, after the addition of black phosphorus nanosheets, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed on the surface of the black phosphorus nanosheets, and the fluorescence of DNA-AgNCs will be restored, and fluorescence can be detected in the system. When the system does not contain black phosphorus nanosheets or HBV DNA target genes, DNA-AgNCs and fluorescence-enhanced DNA do not hybridize with the HBV DNA target gene, and then after the addition of black phosphorus nanosheets, the unhybridized single-stranded DNA-AgNCs and fluorescence-enhanced DNA can be adsorbed on the black phosphorus surface through the van der Waals force between the black phosphorus nanosheets and the bases in the DNA, which quenches the fluorescence of the DNA-AgNCs and makes it impossible to detect fluorescence in the system.
[0166] Example 13
[0167] The present application example provides a fluorescence test for detecting HBV DNA target gene using nanoprobes of different components, and the specific steps include:
[0168] The DNA-AgNCs B of Example 1 and the fluorescence-enhanced DNA E2 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0169] The DNA-AgNCs B of Example 1 and the fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. The mixture was then mixed with 50 μg / mL of two-dimensional zinc oxide nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0170] The DNA-AgNCs B (200 nM) of Example 1 and the fluorescence-enhanced DNA E2 were mixed at a molar ratio of 1:1 to obtain a mixture. Thereafter, the mixture was hybridized with the HBV DNA target gene T2 (200 nM) for 30 minutes, and 50 μg / mL of two-dimensional zinc oxide nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0171] When the HBV DNA target gene is directly mixed with DNA-AgNCs and fluorescence-enhanced DNA, a complementary T-shaped double-stranded structure will be formed first; then, after the addition of two-dimensional zinc oxide nanosheets, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed to the surface of the two-dimensional zinc oxide nanosheets, and the fluorescence of DNA-AgNCs will be restored, and fluorescence can be detected in the system. When the system does not contain two-dimensional zinc oxide nanosheets or HBV DNA target genes, DNA-AgNCs and fluorescence-enhanced DNA do not hybridize with the HBV DNA target gene, and then after the addition of two-dimensional zinc oxide nanosheets, the unhybridized single-stranded DNA-AgNCs and fluorescence-enhanced DNA can be adsorbed on the two-dimensional zinc oxide surface through the van der Waals force between the two-dimensional zinc oxide nanosheets and the bases in the DNA, which quenches the fluorescence of DNA-AgNCs and makes it impossible to detect fluorescence in the system.
[0172] Embodiment 14
[0173] The present application example provides a fluorescence test for detecting HBV DNA target gene using nanoprobes of different components, and the specific steps include:
[0174] The DNA-AgNCs A of Example 1 and the fluorescence-enhanced DNA E1 (200 nM) were mixed and incubated for 10 minutes at a molar ratio of 1:1 to obtain a mixture. The fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0175] DNA-AgNCs A of Example 1 and fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. The mixture was then mixed with 50 μg / mL two-dimensional Mxene nanosheets, and after incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The two-dimensional Mxene nanosheets were titanium carbide (Ti3C2Tx).
[0176] The DNA-AgNCs A (200 nM) of Example 1 and the fluorescence enhanced DNA E1 were mixed at a molar ratio of 1:1 to obtain a mixture. Thereafter, the mixture was hybridized with the HBV DNA target gene T1 (200 nM) for 30 minutes, and 50 μg / mL Mxene nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer.
[0177] When the HBV DNA target gene is directly mixed with DNA-AgNCs and fluorescence-enhanced DNA, a complementary T-shaped double-stranded structure will be formed first; then, after the addition of Mxene nanosheets, the complementary T-shaped double-stranded structure formed by hybridization will not be adsorbed on the surface of the Mxene nanosheets, and the fluorescence of DNA-AgNCs will be restored, and fluorescence can be detected in the system. When the system does not contain Mxene nanosheets or HBV DNA target genes, DNA-AgNCs and fluorescence-enhanced DNA do not hybridize with the HBV DNA target gene, and then after the addition of Mxene nanosheets, the unhybridized single-stranded DNA-AgNCs and fluorescence-enhanced DNA can be adsorbed on the Mxene surface through the van der Waals force between the Mxene nanosheets and the bases in the DNA, which quenches the fluorescence of DNA-AgNCs and makes it impossible to detect fluorescence in the system.
[0178] Embodiment 15
[0179] Fluorescence test of DNA-AgNCs and fluorescence-enhanced DNA to detect different concentrations of HBV DNA target gene:
[0180] DNA-AgNCs A of Example 1 and fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with HBV DNA target gene T1 at a concentration of 0 to 200 nM for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 4 a and Figure 4 As shown in b.
[0181] DNA-AgNCs B of Example 1 and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with HBV DNA target gene T2 at a concentration of 0 to 200 nM for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 4 c and Figure 4 As shown in d.
[0182] Figure 4 This is a fluorescence detection test of the DNA-AgNCs and fluorescence enhanced DNA provided in the examples of the present application to detect HBV DNA target genes of different concentrations. Figure 4 a is the fluorescence emission spectrum of DNA-AgNCs when different concentrations of HBV DNA target gene T1 were added in the presence of MoS2 nanosheets and fluorescence-enhanced DNA E1. Figure 4b is the fluorescence intensity graph of DNA-AgNCs A drawn with different concentrations of HBV DNA target gene T1. Figure 4 b Illustration shows the linear relationship between fluorescence intensity and the concentration of HBV DNA target gene T1 (0-200 nM). Figure 4 c Fluorescence emission spectra of DNA-AgNCs B when different concentrations of HBV DNA target gene T2 were added in the presence of MoS2 nanosheets and fluorescence-enhanced DNA E2. Figure 4 d is the fluorescence intensity graph of DNA-AgNCs B plotted against different concentrations of HBV DNA target gene T2. Figure 4 d Inset shows the linear relationship between fluorescence intensity and HBV DNA target gene T2 concentration (0-200 nM). Error bars are obtained from three parallel experiments.
[0183] Selective test of nanoprobes for HBV DNA target genes with different sequences:
[0184] DNA-AgNCs A of Example 1 and fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with HBV DNA target gene T1 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 5 a The data of HBV group are shown.
[0185] DNA-AgNCs A of Example 1 and fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with SM1 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 5 The data of SM group are shown in a.
[0186] DNA-AgNCs A of Example 1 and fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with TM1 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 5 a The data of TM group are shown.
[0187] DNA-AgNCs A of Example 1 and fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with CM1 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 5 The data of CM group are shown in a.
[0188] DNA-AgNCs B of Example 1 and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with HBV DNA target gene T2 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 5 b The data of HBV group are shown.
[0189] DNA-AgNCs B of Example 1 and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with SM2 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 5 The data of SM group are shown in b.
[0190] DNA-AgNCs B of Example 1 and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with TM2 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 5 Data of TM group are shown in b.
[0191] DNA-AgNCs B of Example 1 and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1 to obtain a mixture. After that, the mixture was hybridized with CM2 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 10 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 5 b The data of CM group are shown.
[0192] Figure 5 For this application, different nanoprobes were used to detect the relative fluorescence intensity of different target genes. Figure 5 Medium FM / F H , where F H is the fluorescence intensity when the target gene is present, and F M It is the fluorescence intensity in the presence of single-base mismatch (SM), triple-base mismatch (TM) and completely mismatched (CM) DNA chains. Figure 5 It can be seen that the nanoprobe provided in the examples of the present application is highly selective for the HBV DNA target gene T1 and the HBV DNA target gene T2.
[0193] Fluorescence test of nanoprobes to detect different amounts of HBV DNA target genes:
[0194] DNA-AgNCs A, DNA-AgNCs B, fluorescence-enhanced DNA E1, and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1:1:1 to obtain a mixture. Then, 50 μg / mL MoS2 nanosheets were added thereto, and after incubation for 30 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in Figure 6 As shown in a.
[0195] DNA-AgNCs A, DNA-AgNCs B, fluorescence-enhanced DNA E1, and fluorescence-enhanced DNA E1 (200 nM) were mixed at a molar ratio of 1:1:1:1 to obtain a mixture. After that, the mixture was hybridized with HBV DNA target gene T1 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 30 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in Figure 6 As shown in b.
[0196] DNA-AgNCs A, DNA-AgNCs B, fluorescence-enhanced DNA E1, and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1:1:1 to obtain a mixture. After that, the mixture was hybridized with HBV DNA target gene T2 (200 nM) for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 30 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in Figure 6 As shown in c.
[0197] DNA-AgNCs A, DNA-AgNCs B, fluorescence-enhanced DNA E1 and fluorescence-enhanced DNA E2 (200 nM) were mixed at a molar ratio of 1:1:1:1 to obtain a mixture. After that, the mixture, HBV DNA target gene T1 (200 nM) and HBV DNA target gene T2 (200 nM) were hybridized for 30 minutes, and 50 μg / mL MoS2 nanosheets were added thereto. After incubation for 30 minutes, the fluorescence spectrum of the solution was scanned using an RF-6000 fluorescence spectrophotometer. The results are shown in FIG. Figure 6 As shown in d.
[0198] Figure 6 The fluorescence spectra of the nanoprobe provided in the embodiments of the present application for detecting different amounts of HBV DNA target genes. Figure 6 d shows that in the presence of MoS2 nanosheets, fluorescence-enhanced DNA E1 and fluorescence-enhanced DNA E2, DNA-AgNCsA, DNA-AgNCs B, HBV DNA target gene T1 and HBV DNA target gene T2 were co-incubated, and the green and red fluorescence emissions were monitored under excitation at 490nm and 593nm, respectively. It can be seen that DNA-AgNCs can be used to detect multiple target genes simultaneously.
[0199] Example 16
[0200] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0201] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid and H2PtCl6 aqueous solutions, respectively. Then, under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China), the reaction mixture was heated at 60°C for 5 minutes to obtain MoS2-PtNPs containing different concentrations of HBV DNA target gene T1.
[0202] The TEM images, AFM images and XPS spectra of MoS2-PtNPs containing 50nM HBV DNA target gene T1 were detected. Figure 7 a. Figure 7 b and Figure 7 As shown in c. Figure 7a is the TEM image of MoS2-PtNPs containing 50 nM HBV DNA target gene T1; Figure 7 b is the AFM image of MoS2-PtNPs containing 50 nM HBV DNA target gene T1; Figure 7 b Inset shows the height profile of MoS2-PtNPs; Figure 7 c is the XPS spectra of MoS2-PtNPs and MOS2 nanosheets containing 50 nM HBV DNA target gene T1.
[0203] Embodiment 17
[0204] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0205] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (500μM) and K2PdCl6 (100μM) aqueous solutions, respectively. The reaction mixture was then stirred at room temperature for 2 hours to obtain MoS2-PdNPs containing different concentrations of HBV DNA target gene T1.
[0206] The present application performs dynamic light scattering and Zeta potential analysis on the MoS2-PdNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results show that the MoS2-PdNPs obtained in Example 17 of the present application have a particle size of approximately 216nm and a potential of approximately -19.5mV.
[0207] Then, 50 μL of MoS2-PdNPs, 25 μL of H2O2 (final concentration of 50 mM) and 8 μL of TMB (final concentration of 800 μM) were mixed into PBS buffer (400 μL, pH 4.0, 25 mM) in turn, and the changes were observed after incubation for 10 minutes. It was found that as the concentration of the HBVDNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0208] Embodiment 18
[0209] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0210] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (500μM) and HAuCl4 (100μM) aqueous solutions, respectively. The reaction mixture was then stirred at room temperature for 2 hours to obtain MoS2-AuNPs containing different concentrations of HBV DNA target gene T1.
[0211] The present application performed dynamic light scattering and Zeta potential analysis on the MoS2-AuNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results showed that the particle size of the MoS2-AuNPs obtained in Example 18 of the present application was approximately 208nm and the potential was -18.6mV.
[0212] Then, the synthesized MoS2-AuNPs, H2O2 (50mM) and TMB (800μM) were mixed into PBS buffer (pH4.0, 25mM) in turn, incubated for 10 minutes, and the color change was observed. The experiment confirmed that as the concentration of HBV DNA target gene increased, the color of TMB gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0213] Embodiment 19
[0214] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0215] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with NaBH4 (300μM) and AgNO3 (100μM) aqueous solutions, respectively. The reaction mixture was then stirred at room temperature for 1 hour to obtain MoS2-AgNPs containing different concentrations of HBV DNA target gene T1.
[0216] The present application performed dynamic light scattering and Zeta potential analysis on the MoS2-AgNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results showed that the particle size of the MoS2-AgNPs obtained in Example 19 of the present application was approximately 212nm and the potential was -21.3mV.
[0217] Then, the synthesized MoS2-AgNPs, H2O2 (final concentration of 50mM) and TMB (final concentration of 800μM) were mixed into PBS buffer (pH 4.0, 25mM), and the color change was observed after 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0218] Embodiment 20
[0219] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0220] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (400μM) and CuCl2 (100μM) aqueous solutions, respectively. The reaction mixture was then stirred at room temperature for 2 hours to obtain MoS2-CuNPs containing different concentrations of HBV DNA target gene T1.
[0221] The present application performs dynamic light scattering and Zeta potential analysis on the MoS2-CuNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results show that the particle size of the MoS2-CuNPs obtained in Example 20 of the present application is approximately 205nm and the potential is -22.5mV.
[0222] Then, MoS2-CuNPs, H2O2 (final concentration of 50mM) and TMB (final concentration of 800μM) containing different concentrations of target genes were mixed into PBS buffer (400μL, pH 4.0, 25mM) in turn, and the changes were observed after incubation for 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0223] Embodiment 21
[0224] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0225] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (500μM), H2PtCl6 (50μM) and K2PdCl6 (50μM) aqueous solutions, respectively. The reaction mixture was then heated at 60°C for 5 minutes under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China) to obtain MoS2-Pt / PdNPs containing target genes at different concentrations.
[0226] The present application performs dynamic light scattering and Zeta potential analysis on the MoS2-Pt / PdNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results show that the MoS2-Pt / PdNPs obtained in Example 21 of the present application have a particle size of approximately 230nm and a potential of -12.3mV.
[0227] Then, the above-mentioned MoS2-Pt / PdNPs, H2O2 (final concentration of 50mM) and TMB (final concentration of 800μM) containing different concentrations of target genes were mixed into PBS buffer (pH 4.0, 25mM) in turn, and the changes were observed after incubation for 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0228] Embodiment 22
[0229] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0230] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (500μM), H2PtCl6 (50μM) and HAuCl4 (50μM) aqueous solutions, respectively. The reaction mixture was then heated at 60°C for 5 minutes under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China) to obtain MoS2-Pt / AuNPs containing target genes at different concentrations.
[0231] The present application performed dynamic light scattering and Zeta potential analysis on the MoS2-Pt / AuNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results showed that the particle size of the MoS2-Pt / AuNPs obtained in Example 22 of the present application was approximately 206nm and the potential was -11.6mV.
[0232] Then, the above MoS2-Pt / AuNPs, H2O2 (50mM) and TMB (800μM) containing different concentrations of target genes were mixed into PBS buffer (pH 4.0, 25mM) in turn, and the changes were observed after incubation for 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0233] Embodiment 23
[0234] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0235] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (500μM), H2PtCl6 (80μM) and AgNO3 (20μM) aqueous solutions, respectively. The reaction mixture was then heated at 60°C for 5 minutes under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China) to obtain MoS2-Pt / AgNPs containing target genes at different concentrations.
[0236] The present application performed dynamic light scattering and Zeta potential analysis on the MoS2-Pt / AgNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results showed that the particle size of the MoS2-Pt / AgNPs obtained in Example 23 of the present application was approximately 212nm and the potential was -13.6mV.
[0237] Then, the above MoS2-Pt / AgNPs containing different concentrations of target genes, 25μL H2O2 (final concentration of 50mM) and 8μLTMB (final concentration of 800μM) were mixed into PBS buffer (pH 4.0, 25mM) in turn, and the changes were observed after incubation for 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0238] Embodiment 24
[0239] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0240] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (500μM), H2PtCl6 (80μM) and CuCl2 (20μM) aqueous solutions, respectively. The reaction mixture was then heated at 60°C for 5 minutes under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China) to obtain MoS2-Pt / CuNPs containing target genes at different concentrations.
[0241] The present application performed dynamic light scattering and Zeta potential analysis on the MoS2-Pt / CuNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results showed that the particle size of the MoS2-Pt / CuNPs obtained in Example 24 of the present application was approximately 225nm and the potential was -9.8mV.
[0242] Then, the above MoS2-Pt / CuNPs, H2O2 (50mM) and TMB (final 800μM) were mixed into PBS buffer (pH4.0, 25mM) in turn, and the changes were observed after incubation for 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0243] Embodiment 25
[0244] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0245] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with NaBH4 (500μM), AgNO3 (50μM) and CuCl2 (50μM) aqueous solutions, respectively. The reaction mixture was then stirred at room temperature for 2 hours to obtain MoS2-Ag / CuNPs containing target genes at different concentrations.
[0246] The present application performed dynamic light scattering and Zeta potential analysis on the MoS2-Ag / CuNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results showed that the particle size of the MoS2-Ag / CuNPs obtained in Example 25 of the present application was approximately 225nm and the potential was -9.8mV.
[0247] Then, the above MoS2-Ag / CuNPs, H2O2 (50mM) and TMB (800μM) containing different concentrations of target genes were mixed into PBS buffer (pH 4.0, 25mM) in turn, and the changes were observed after incubation for 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0248] Embodiment 26
[0249] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0250] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (500μM), HAuCl4 (30μM), K2PdCl6 (20μM) and H2PtCl6 (50μM) aqueous solutions, respectively. The reaction mixture was then stirred at room temperature for 2 hours to obtain MoS2-Au / Pd / PtNPs containing target genes at different concentrations.
[0251] The present application performs dynamic light scattering and Zeta potential analysis on the MoS2-Au / Pd / PtNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results show that the MoS2-Au / Pd / PtNPs obtained in Example 26 of the present application have a particle size of approximately 210nm and a potential of -15.6mV.
[0252] Then, the above-mentioned MoS2-Au / Pd / PtNPs, H2O2 (final concentration of 50mM) and TMB (final concentration of 800μM) containing different concentrations of target genes were mixed into PBS buffer (pH 4.0, 25mM) in turn, and their changes were observed after incubation for 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0253] Embodiment 27
[0254] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0255] The probe DNA P1 (50nM) and 0pM to 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid (500μM), HAuCl4 (30μM), AgNO3 (20μM) and H2PtCl6 (50μM) aqueous solutions, respectively. The reaction mixture was then stirred at room temperature for 2 hours to obtain MoS2-Au / Ag / PtNPs containing target genes at different concentrations.
[0256] The present application performed dynamic light scattering and Zeta potential analysis on the MoS2-Au / Ag / PtNPs obtained in the presence of probe DNA P1 (50nM) and HBV DNA target gene T1 (50nM). The test results showed that the particle size of the MoS2-Ag / Au / Ag / PtNPs obtained in Example 27 of the present application was approximately 216nm and the potential was -16.9mV.
[0257] Then, the above MoS2-Au / Ag / PtNPs, H2O2 (final concentration of 50mM) and TMB (final concentration of 800μM) were mixed into PBS buffer (pH 4.0, 25mM) in turn, and the changes were observed after incubation for 10 minutes. It was found that as the concentration of HBV DNA target gene increased, the color of the solution gradually deepened, proving that the visual colorimetric detection of disease-related target genes can be effectively achieved.
[0258] Embodiment 28
[0259] The present application example provides an experiment for detecting HBV DNA target gene by nanoprobe using colorimetric method, and the specific method includes:
[0260] 1. 50 μL of MoS2-PtNPs of Example 16, 25 μL of H2O2 (final concentration of 50 mM) and 8 μL of TMB (final concentration of 800 μM) were sequentially mixed into PBS buffer (400 μL, pH 4.0, 25 mM). After incubation for 10 minutes, the catalytic activity was detected by UV-vis absorbance, and the absorbance change at 652 nm over time was detected.
[0261] The absorbance changes and appearance colors of MoS2 nanosheets, MoS2-PtNPs without HBV DNA target gene T1, and MoS2-PtNPs containing 50nM HBV DNA target gene T1 at 652nm were measured over time. Figure 7 The top solutions in d are, from left to right, the appearance colors of MoS2 nanosheets at 652nm, the appearance colors of MoS2-PtNPs without HBV DNA target gene T1 at 652nm, and the appearance colors of MoS2-PtNPs containing 50nM HBV DNA target gene T1 at 652nm. Figure 7 As shown in d, Figure 7 Curve 1 of d is the absorbance change of MoS2 nanosheets at 652nm over time. Figure 7 Curve 2 of d shows the absorbance change of MoS2-PtNPs at 652 nm with time in the presence of probe DNA P1 and the absence of HBV DNA target gene T1. Figure 7Curve 3 of d shows the absorbance change of MoS2-PtNPs containing 50 nM HBV probe DNA P1 and target gene T1 at 652 nm as a function of time.
[0262] Figure 7 d It can be seen that the embodiment of the present application successfully prepared MoS2-PtNPs containing 50nM HBV DNA target gene T1, and the absorbance of MoS2-PtNPs, TMB and H2O2 containing 50nM HBV DNA target gene T1 at 652nm increased with time, and TMB was visible to the naked eye.
[0263] 2. 50 μL of the above-mentioned MoS2-PtNPs containing 0 pM to 50 nM HBV DNA target gene T1, 25 μL of H2O2 (final concentration of 50 mM) and 8 μL of TMB (final concentration of 800 μM) were mixed into PBS buffer (400 μL, pH 4.0, 25 mM) in sequence. After incubation for 10 minutes, the catalytic activity was detected by UV-vis absorbance. The typical absorption spectrum and appearance color of TMB of MoS2-PtNPs containing 0 pM to 50 nM HBV DNA target gene T1 at 300 to 900 nm were detected. The results are as follows: Figure 8 As shown in a, a is the typical absorption spectrum and appearance color of the solution at 300-900nm containing different concentrations of HBV DNA target gene T1 and MoS2-PtNPs as nanozymes in the presence of H2O2 and TMB. Figure 8 a The top solutions from left to right are the color results of MoS2-PtNPs containing 0pM, 50pM, 100pM, 500pM, 1nM, 5nM, 10nM, 20nM, and 50nM HBV DNA target gene T1. The relationship between the absorbance of TMB at 652nm of MoS2-PtNPs containing 0pM to 50nM HBV DNA target gene T1 and different concentrations of HBV DNA target gene T1. The error bars represent the standard deviation of three measurements. The results are shown in Figure 8 b. The linear calibration graph of the absorbance of TMB at 652 nm of MoS2-PtNPs containing 0pM to 50nM HBV DNA target gene T1 and different concentrations of HBV DNA target gene T1 is shown in the following figure. Figure 8 As shown in c.
[0264] 50nM probe DNA P1 and 50nM HBV DNA target gene T1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid and H2PtCl6 aqueous solutions, respectively. Then, under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China), the reaction mixture was heated at 60°C for 5 minutes to obtain MoS2-PtNPs (i.e., a two-dimensional material-metal nanoparticle complex, MoS2-PtNPs complex nanozyme) containing the HBV DNA target gene T1. 50 μL of the above MoS2-PtNPs composite nanozyme, 25 μL of H2O2 (final concentration of 50 mM) and 8 μL of TMB (final concentration of 800 μM) were mixed into PBS buffer (400 μL, pH 4.0, 25 mM) in sequence. After incubation for 10 minutes, the catalytic activity was detected by UV-vis absorbance. The absorbance at 652 nm and the appearance color were detected. The results are shown in Figure 2. Figure 8 d The data of HBV group are shown.
[0265] 50nM probe DNA P1 and 50nM SM1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid and H2PtCl6 aqueous solution, respectively. Then, under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China), the reaction mixture was heated at 60°C for 5 minutes to obtain MoS2-PtNPs containing SM1 (i.e., a two-dimensional material-metal nanoparticle complex, MoS2-PtNPs complex nanozyme). 50 μL of the above MoS2-PtNPs composite nanozyme, 25 μL of H2O2 (final concentration of 50 mM) and 8 μL of TMB (final concentration of 800 μM) were mixed into PBS buffer (400 μL, pH 4.0, 25 mM) in sequence. After incubation for 10 minutes, the catalytic activity was detected by UV-vis absorbance. The absorbance at 652 nm and the appearance color were detected. The results are shown in Figure 2. Figure 8 d The data of SM group are shown.
[0266] 50nM probe DNAP1 and 50nM TM1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid and H2PtCl6 aqueous solutions, respectively. Then, under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China), the reaction mixture was heated at 60°C for 5 minutes to obtain MoS2-PtNPs containing TM1 (i.e., a two-dimensional material-metal nanoparticle complex, MoS2-PtNPs complex nanozyme). 50 μL of the above MoS2-PtNPs composite nanozyme, 25 μL of H2O2 (final concentration of 50 mM) and 8 μL of TMB (final concentration of 800 μM) were mixed into PBS buffer (400 μL, pH 4.0, 25 mM) in sequence. After incubation for 10 minutes, the catalytic activity was detected by UV-vis absorbance. The absorbance at 652 nm and the appearance color were detected. The results are shown in Figure 2. Figure 8 d The data of TM group are shown.
[0267] 50nM probe DNA P1 and 50nM CM1 were hybridized for 30 minutes, and then 50μg / mL MoS2 nanosheets were added. The DNA-MoS2 complex was collected by centrifugation and then redispersed in the solution to obtain a DNA-MoS2 aqueous dispersion. The above DNA-MoS2 aqueous dispersion was mixed with ascorbic acid and H2PtCl6 aqueous solution, respectively. Then, under microwave irradiation in a microwave reactor (WX-6000, PreeKem Corporation, China), the reaction mixture was heated at 60°C for 5 minutes to obtain MoS2-PtNPs containing CM1 (i.e., a two-dimensional material-metal nanoparticle complex, MoS2-PtNPs complex nanozyme). 50 μL of the above MoS2-PtNPs composite nanozyme, 25 μL of H2O2 (final concentration of 50 mM) and 8 μL of TMB (final concentration of 800 μM) were mixed into PBS buffer (400 μL, pH 4.0, 25 mM) in sequence. After incubation for 10 minutes, the catalytic activity was detected by UV-vis absorbance. The absorbance at 652 nm and the appearance color were detected. The results are shown in Figure 2. Figure 8 d The data of CM group are shown.
[0268] Figure 8 is the absorbance in the presence of HBV DNA target gene T1, HBV DNA single base mismatch target gene (SM1), HBV DNA three base mismatch target gene (TM1) and HBV DNA three base mismatch target gene (CM1), Figure 8It can be seen that the nanoprobe provided in the examples of the present application is highly selective for different HBV DNA target genes.
[0269] It can be seen that the nanoprobe disclosed in the embodiments of the present application can realize the use of disease-related target genes to regulate the growth of metal nanoparticles on the surface of two-dimensional MoS2 nanomaterials; and use the metal-two-dimensional MoS2 nanomaterial nanocomposite system to realize fluorescence and colorimetric dual-channel detection of disease-related target genes.
[0270] The above is only a preferred implementation of the present application. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present application. These improvements and modifications should also be regarded as the scope of protection of the present application. Sequence Listing <110> The Third Affiliated Hospital of Sun Yat-sen University (Sun Yat-sen University Liver Hospital) Sun Yat-sen University <120> A nanoprobe and its preparation method and application <130> MP21005987 <160> 7 <170> SIPOSequenceListing 1.0 <210> 1 <211> 32 <212> DNA <213> Artificial Sequence <400> 1 cccatatacc ccggtgcagt ttccgtccgt ag 32 <210> 2 <211> 26 <212> DNA <213> Artificial Sequence <400> 2 ccccacccctcccccaactcctccca 26 <210> 3 <211> 35 <212> DNA <213> Artificial Sequence <400> 3 acctttaacc taatctcctc ccccaactcc tccca 35 <210> 4 <211> 38 <212> DNA <213> Artificial Sequence <400> 4 atgatgggta tgggaataca gggtggggtg gggtgggg 38 <210> 5 <211> 27 <212> DNA <213> Artificial Sequence <400> 5 acctttaacctaatctcctcccgtttt 27 <210> 6 <211> 40 <212> DNA <213> Artificial Sequence <400> 6 ctacggacgg aaactgcacc tgtattccca tacccatcat 40 <210> 7 <211> 35 <212> DNA <213> Artificial Sequence <400> 7 tgggaggagt tgggggagga gattaggtta aaggt 35
Claims
1. A fluorescent and colorimetric visualization nanoprobe, characterized in that: include: Two-dimensional materials and probe DNA; The two-dimensional material is a two-dimensional material that can adsorb the probe DNA, or the two-dimensional material can be used as a substrate to synthesize a two-dimensional material-metal nanoparticle complex for catalytic colorimetric detection; The probe DNA can be complementary to the target gene associated with the disease; The binding force between the complementary pairing of the probe DNA and the target gene is greater than the binding force between the probe DNA and the two-dimensional material; Also included is fluorescence-enhanced DNA; The fluorescence-enhanced DNA forms a complementary pair with a portion of the target gene DNA; so that the fluorescence-enhanced DNA, the probe DNA and the target gene complementarily pair to form a hybrid structure; The probe DNA is a nucleotide sequence as shown in SEQ ID No: 1; the fluorescence enhancement DNA is a nucleotide sequence as shown in SEQ ID No: 4; The two-dimensional material is selected from one or more of molybdenum disulfide nanosheets, tungsten disulfide nanosheets, graphene nanosheets, black phosphorus nanosheets, and two-dimensional Mxene; the probe DNA is used to prepare a metal cluster probe; the fluorescent metal cluster of the metal cluster probe is selected from one or more of silver nanoclusters, gold nanoclusters, platinum nanoclusters, copper nanoclusters, gold-silver nanoclusters, and platinum-silver nanoclusters; When the two-dimensional material is used as a substrate to synthesize a two-dimensional material-metal nanoparticle complex for catalytic colorimetric detection, the metal nanoparticles are selected from one or more of platinum nanoparticles, palladium nanoparticles, gold nanoparticles, silver nanoparticles, copper nanoparticles, palladium-platinum nanoparticles, platinum-gold nanoparticles, platinum-silver nanoparticles, platinum-copper nanoparticles, silver-copper nanoparticles, gold-palladium-platinum nanoparticles and gold-silver-platinum nanoparticles; The preparation method of the two-dimensional material-metal nanoparticle composite comprises: The two-dimensional material, a soluble metal salt solution and a reducing agent are mixed and reacted to prepare a two-dimensional material-metal nanoparticle composite.
2. The method for preparing the nanoprobe according to claim 1, characterized in that: The preparation method of the metal cluster probe comprises: The probe DNA, a soluble metal salt solution and a reducing agent are mixed and reacted to prepare a metal cluster probe.
3. Use of the nanoprobe according to claim 1 or the nanoprobe prepared by the preparation method according to claim 2 in the preparation of a target gene product for detecting disease-related diseases.
4. A kit for detecting a disease-related target gene, characterized in that: include: The nanoprobe according to claim 1 or the nanoprobe prepared by the preparation method according to claim 2, a reducing agent, a metal salt solution, H2O2, a color developer and a buffer solution.
